NCT02308501View on ClinicalTrials.gov

A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

February 28, 2015

Study Completion Date

February 28, 2015

Conditions
Allergic Conjunctivitis
Interventions
DRUG

Lastacaft ®

DRUG

Tears Naturale ® (Placebo)

All Listed Sponsors
lead

ORA, Inc.

INDUSTRY

NCT02308501 - A Single-Center Evaluation of the Anti-Inflammatory Effects of Lastacaft as Measured by In-Vivo Confocal Microscopy | Biotech Hunter | Biotech Hunter